MarketPeel
Insider Trading Intelligence
MK

Mohit Kaushal

TOI
DIRECTOR · ONCOLOGY INSTITUTE, INC. · CIK 0001683021
FILING MIX · LIFETIME59%/41%
BUYS
10
SELLS
7
TOTAL VALUE
$393.0K
COMPANIES
1
ACTIVE SINCE
Nov 2021
HOLDINGS NOW
172,583
AVG SELL PX
$3.37
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 8 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Mohit Kaushal, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+75.00%-10.14%+1.04%-11.18%-9.68%
14d4+50.00%-13.96%+1.35%-15.31%-16.72%
30d4+50.00%-21.44%+5.00%-26.43%-22.03%
60d4+50.00%-1.40%+3.84%-5.24%+5.76%
90d4(2 pending)+100.00%-49.18%+5.60%-54.77%-54.77%
180d4(2 pending)+100.00%-82.59%+7.38%-89.97%-89.97%
1y4(2 pending)+50.00%-26.68%+14.46%-41.15%-41.15%
2y4(2 pending)+100.00%-90.25%+56.33%-146.58%-146.58%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TOI · 172,583 shares · as of Apr 16, 2026
067,076134,151201,227268,30220222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 10 buys / 7 sellsCOVERAGE · 19 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TOI
ONCOLOGY INSTITUTE, INC.
SALE10b5-1
10b5-1 plan
38,433$3.50$134.5K172,583Apr 16, 2026Apr 16, 2026View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE10b5-1
10b5-1 plan
57,286$3.50$200.6K211,016Apr 14, 2026Apr 16, 2026View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
50,926228,179Nov 20, 2025Nov 24, 2025View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
40,123268,302Nov 20, 2025Nov 24, 2025View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
56,000177,253Nov 22, 2024Nov 25, 2024View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
53,326121,253Dec 26, 2023Dec 28, 2023View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
19,68542,393Mar 17, 2023Mar 21, 2023View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
22,70848,242Nov 17, 2022Nov 21, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
15,994$2.13$34.1K25,534Nov 14, 2022Nov 15, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
4,798$4.96$23.8K41,528Oct 24, 2022Oct 25, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
4,79846,326Mar 21, 2022Mar 23, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
15,99441,528Mar 21, 2022Mar 23, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
30,0000Nov 12, 2021Nov 16, 2021View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
4,46625,534Nov 12, 2021Nov 16, 2021View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
30,00030,000Nov 12, 2021Nov 16, 2021View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
30,0000Nov 12, 2021Nov 18, 2021View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
30,00030,000Nov 12, 2021Nov 18, 2021View →
Other insiders · TOI
Loading peer insiders…
About this filer
CIK 0001683021
ROLE
Director
PRIMARY
TOI
COMPANIES
1
ACTIVE SINCE
Nov 2021
MARKETPEEL · /INSIDER/0001683021DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback